articl
summar
contribut
high
throughput
genom
proteom
metabolom
gene
express
investig
understand
inherit
acquir
risk
acut
respiratori
distress
syndrom
ard
yet
wide
appli
complex
trait
like
ard
techniqu
routin
employ
studi
varieti
diseas
state
omic
applic
hold
great
promis
identifi
novel
factor
may
contribut
ard
pathophysiolog
may
appropri
develop
biomark
surrog
clinic
studi
opportun
challeng
differ
techniqu
discuss
exampl
success
applic
nonard
field
use
illustr
potenti
util
techniqu
futur
gwa
publish
new
candid
undoubtedli
emerg
metaanalysi
possibl
har
power
multipl
popul
time
howev
gwa
may
prove
fruit
heterogen
ard
acknowledg
priori
analys
conduct
within
homogen
subtyp
instanc
tejera
christiani
demonstr
genet
risk
factor
extrapulmonari
ard
pulmonari
ard
distinct
find
echo
review
addit
meyer
acut
respiratori
distress
syndrom
ard
inflict
consider
morbid
mortal
among
critic
ill
patient
lack
specif
pharmacolog
therapi
clinic
factor
alon
fail
explain
patient
ard
risk
factor
develop
syndrom
accur
predict
patient
die
result
ard
great
interest
understand
whether
one
could
leverag
new
biolog
techniqu
better
character
risk
prognosi
major
advanc
field
genom
mass
spectroscopi
bioinformat
numer
approach
appli
complex
trait
like
ard
yet
benefit
uncertain
tabl
goal
paper
review
state
knowledg
genet
contribut
ard
risk
mortal
briefli
review
broader
applic
genom
ard
pathogenesi
consid
exampl
nonard
field
wherebi
genom
approach
yield
major
advanc
appli
similar
approach
ard
may
deepen
understand
offer
new
therapeut
paradigm
patient
ard
mani
investig
associ
word
genom
inherit
condit
obvious
cluster
among
famili
report
famili
ard
affect
multipl
member
one
might
conclud
genom
would
offer
littl
understand
ard
howev
altern
perspect
consid
ard
pattern
respons
injuri
pneumonia
sepsi
trauma
trait
respons
injuri
signific
herit
fact
death
infect
herit
condit
studi
larg
danish
registri
adopte
much
stronger
herit
vascular
diseas
cancer
rather
act
monogenet
mendelian
trait
wherebi
singl
genet
variat
explain
bulk
observ
phenotyp
ard
risk
sever
like
influenc
multipl
genet
variant
contribut
modest
degre
small
effect
size
contribut
gene
variant
mandat
larg
studi
popul
detect
addit
ard
ripe
util
intermedi
trait
identif
endotyp
subtyp
may
demonstr
homogen
genet
background
numer
candid
gene
associ
studi
report
ard
sever
reproduc
associ
emerg
complet
review
genet
associ
ard
risk
ard
mortal
beyond
scope
present
review
comprehens
review
recent
publish
best
replic
genet
variant
ard
risk
repres
present
understand
ard
pathophysiolog
proand
antiinflammatori
cytokin
gene
polymorph
well
repres
vascular
injuri
marker
vegfa
ace
mylk
innat
immun
pathway
member
nfkbia
fa
marker
respiratori
epitheli
injuri
sftpb
associ
associ
ard
risk
outcom
least
popul
none
influenc
ard
risk
sever
degre
warrant
genet
test
atrisk
popul
instead
main
contribut
ard
genet
associ
date
focu
attent
molecular
pathway
play
caus
perpetu
syndrom
tempt
specul
genet
associ
may
highlight
potenti
therapeut
target
either
prevent
ard
improv
outcom
develop
exampl
associ
variant
gene
ard
risk
mix
icu
popul
trauma
popul
coupl
strong
anim
evid
antagon
protein
augment
counterpart
result
decreas
mortal
suggest
may
help
block
protein
human
risk
ard
given
numer
fail
trial
prevent
treat
ard
howev
may
investig
seek
molecular
marker
high
plasma
protein
level
carriag
genet
variant
enrich
clinic
trial
popul
subject
like
respond
similar
case
could
made
use
human
neutrophil
elastas
hne
inhibitor
alreadi
use
japan
treat
ard
albeit
scant
evid
efficaci
sinc
gene
preelafin
evid
dysregul
among
patient
fail
resolv
ard
function
promot
variant
associ
ard
sinc
plasma
level
gene
product
elafin
reduc
ard
patient
perhap
patient
low
elafin
level
high
hne
activ
would
like
respond
hne
inhibitor
angiotensin
convert
enzym
ace
gene
also
may
suggest
therapeut
strategi
ace
gene
variant
increas
level
associ
ard
mortal
counterregulatori
enzym
seem
decreas
lung
injuri
earliest
contribut
genom
understand
ard
success
leverag
anim
model
quantit
trait
bioinformat
grigoryev
colleagu
use
bioinformat
approach
find
overlap
gene
express
messeng
rna
mrna
level
human
cell
anim
lung
tissu
subject
repeat
mechan
stress
model
ventilatorinduc
injuri
orthologu
gene
common
structur
function
across
differ
speci
behav
reproduc
manner
across
numer
model
injuri
subsequ
investig
mous
knockout
model
gene
silenc
manner
ye
colleagu
identifi
preb
cell
coloni
enhanc
factor
pbef
also
known
gene
name
nampt
regul
inflammatori
cytokin
turn
caus
epitheli
endotheli
permeabl
addit
independ
group
replic
associ
promot
variant
nampt
develop
ard
new
candid
gene
also
aris
screen
multipl
rodent
speci
differenti
suscept
lung
injuri
leikauf
colleagu
perform
use
inhal
injuri
model
translat
anim
vitro
work
human
popul
howev
choic
experiment
model
highli
relev
do
santo
colleagu
demonstr
gene
express
respons
ventilatorinduc
lung
injuri
distinct
endotoxin
model
sepsi
conson
find
human
popul
gene
variant
associ
ard
may
specif
ard
risk
factor
first
publish
human
genomewid
associ
studi
gwa
ard
suscept
christi
colleagu
identifi
novel
locu
liprin
alpha
replic
risk
factor
ard
follow
trauma
littl
known
liprin
alpha
would
contribut
lung
injuri
time
discoveri
subsequ
work
implic
liprin
alpha
bind
partner
downregul
mammalian
homolog
diaphan
mdia
rho
effector
mediat
stress
fiber
format
nonmuscl
myosin
light
chain
kinas
critic
regul
endotheli
cytoskeleton
implic
ard
liprin
alpha
may
also
prove
relev
barrier
enhanc
ard
precipit
factor
ancestri
gender
age
comorbid
may
import
furthermor
given
notabl
heterogen
ard
almost
certaintli
addit
subtyp
may
becom
appar
addit
data
elegantli
proven
calfe
colleagu
appli
latent
class
analysi
popul
nhlbi
ard
network
sinc
unbias
model
suggest
class
patient
ard
one
character
higher
inflammatori
cytokin
plasma
level
lower
plasma
bicarbon
tendenc
shock
subclass
dramat
differ
outcom
respons
high
posit
endexpiratori
pressur
may
leverag
gwa
within
subclass
would
yield
import
insight
process
drive
type
ard
addit
anim
studi
mention
sever
human
investig
explor
util
gene
express
identifi
novel
candid
gene
ard
gene
express
analysi
advantag
sinc
output
analysi
quantit
trait
offer
strong
statist
power
rel
dichotom
trait
like
presenc
absenc
ard
addit
mrna
reflect
matur
transcript
translat
protein
chang
transcript
abund
like
function
thu
offer
strong
evid
involv
trait
final
multidimension
analysi
global
gene
express
chang
possibl
use
microarray
technolog
wherebi
small
amount
start
mrna
assess
roughli
transcript
simultan
techniqu
effici
way
assess
gene
express
level
also
allow
multidimension
analyt
strategi
defin
pattern
express
two
gener
type
analys
perform
supervis
hierarch
analysi
sampl
assign
class
investig
unbias
machin
learn
analysi
wherebi
analysi
seek
detect
unobserv
pattern
unlabel
data
earli
exampl
hierarch
analysi
involv
demonstr
gene
express
chang
acut
myelogen
leukemia
aml
bone
marrow
mononuclear
cell
distinct
acut
lymphogen
leukemia
cell
subsequ
group
perform
similar
genom
wide
express
analysi
blast
cell
unsupervis
manner
identifi
major
molecular
subtyp
reflect
differ
biolog
mechan
suggest
differenti
respons
treatment
express
pattern
specif
factor
tumor
tissu
routin
assay
hematolg
solid
organ
malign
effort
person
therapi
research
ard
transcriptom
hamper
lack
avail
lung
tissu
upon
perform
microarray
analysi
sinc
minor
patient
less
progress
lung
biopsi
without
lung
tissu
investig
reli
upon
gene
express
either
specif
blood
cell
popul
white
blood
cell
collect
whole
blood
whole
blood
rel
conveni
way
sampl
rna
collect
method
may
introduc
variabl
never
reflect
express
pattern
lung
endothelium
epithelium
sinc
gene
express
cellspecif
figur
one
first
descript
appli
microarray
technolog
human
ard
howrylak
colleagu
report
global
whole
blood
gene
express
patient
sepsi
ard
compar
sepsi
alon
report
differenti
express
transcript
distinguish
patient
ard
dysregul
transcript
encod
heavi
subunit
ferritin
interest
given
role
iron
catalyz
reactiv
oxygen
speci
ro
potenti
contribut
ro
toward
lung
injuri
novel
approach
appli
wang
colleagu
compar
whole
blood
gene
express
profil
patient
acut
ard
convalesc
allow
patient
control
filter
much
background
variabl
express
across
individu
use
approach
investig
identifi
peptidas
inhibitor
gene
encod
elafin
downregul
ard
function
promot
variant
associ
lower
cytokineinduc
transcript
activ
greater
sepsisassoci
ard
potenti
act
durabl
bind
preelafin
extracellular
matrix
protein
date
larg
systemat
applic
gene
express
human
sampl
ard
furthermor
remain
unclear
whether
signatur
obtain
whole
blood
circul
leukocyt
provid
relev
answer
condit
alveolar
epitheli
endotheli
dysfunct
question
remain
suitabl
studi
whole
blood
gain
insight
lungcentr
condit
advanc
made
appli
approach
sepsi
gener
consid
system
vascular
disord
wong
colleagu
perform
unbias
cluster
analysi
whole
blood
gene
express
approxim
septic
children
identifi
subclass
correl
differenti
mortal
highest
mortal
subclass
character
signific
downregul
gene
annot
glucocorticoid
signal
adapt
immun
system
zincrel
biolog
investig
abl
extend
find
analyz
secret
protein
product
dysregul
gene
highmort
group
result
decis
tool
reliabl
identifi
higher
risk
group
death
appli
children
adult
septic
shock
thu
despit
limit
whole
blood
even
leukocyt
gene
express
inform
lung
tissu
express
larg
scale
peripher
blood
gene
express
may
yield
advanc
ard
field
transcriptom
date
domin
microarray
studi
quantifi
mrna
transcriptom
encompass
form
rna
includ
transfer
rna
ribosom
rna
mani
form
noncod
rna
scienc
noncod
rna
molecul
explod
past
year
identif
multipl
new
class
nonprotein
code
entiti
emerg
understand
complex
role
regul
gene
express
advanc
next
gener
sequenc
capabl
coupl
improv
bioinformat
support
effici
scale
fuel
high
throughput
sequenc
rna
target
genomewid
approach
technolog
rna
sequenc
nascent
publish
report
appli
method
complex
trait
like
ard
howev
applic
rnaseq
cancer
cardiovascular
trait
may
exemplifi
use
approach
futur
microrna
mirna
describ
understood
small
roughli
rna
sequenc
typic
bind
untransl
region
target
mrna
inhibit
translat
promot
mrna
degrad
candid
gene
influenc
ard
includ
mylk
pbefnampt
regul
mirna
rais
possibl
engin
mirna
antagonist
may
therapeut
strategi
futur
cancer
circul
mirna
profil
plasma
investig
biomark
diagnost
prognost
util
approach
may
prove
fruit
ard
anoth
yet
underexplor
aspect
genom
regul
ard
whether
epigenet
modif
influenc
diseas
suscept
outcom
epigenet
chang
classic
constru
herit
chang
gene
express
function
activ
occur
without
chang
dna
sequenc
might
occur
due
chang
dna
methyl
histon
modif
gene
silenc
imprint
epigenet
mechan
attract
explan
sever
gene
environ
interact
thu
may
relev
complex
trait
like
ard
manifest
set
sever
environment
insult
like
mechan
ventil
system
infect
sever
trauma
much
understand
surround
dna
methyl
histon
modif
come
cancer
biolog
tumorsuppressor
gene
hypermethyl
lead
transcript
silenc
promot
tumorigenesi
histon
dynam
regul
process
includ
acetyl
methyl
phosphoryl
ubiquitinyl
result
dynam
effect
gene
express
chromatin
structur
differenti
epigenet
regul
assess
either
target
unbias
genomewid
approach
leverag
bisulfit
sequenc
methyl
andor
mass
spectrometri
detect
posttransl
histon
modif
given
evid
encyclopedia
dna
element
encod
project
highlight
vast
complex
genom
regul
futur
studi
explor
role
epigenom
variat
context
ard
potenti
distinct
ard
precipit
assum
gene
express
would
adequ
describ
state
express
protein
bodi
site
cellular
compart
correl
mrna
protein
profil
surprisingli
poor
understand
differenti
regul
protein
rel
gene
express
enabl
better
understand
altern
splice
posttransl
regul
focus
express
protein
aid
identif
biomark
diagnosi
prognosi
potenti
mechanist
import
proteom
approach
gener
conceiv
largescal
analys
go
beyond
individu
even
multiplex
protein
quantif
enzymelink
immunosorb
assay
elisa
beadbas
immunoassay
parallel
explos
next
gener
sequenc
technolog
analyz
genom
advanc
matrixassist
laser
desorptionion
timeofflight
malditof
mass
spectrometri
analyz
high
dimension
protein
popul
includ
identif
unknown
protein
year
ago
bowler
colleagu
perform
dimension
electrophoresi
follow
mass
spectrometri
upon
edema
fluid
subject
ard
compar
healthi
control
compar
healthi
subject
alveolar
fluid
albumin
transferrin
igg
clusterin
increas
surfact
protein
decreas
ard
patient
addit
sever
protein
detect
alveolar
fluid
ard
subject
demonstr
signific
posttransl
modif
schnapp
group
univers
washington
appli
liquid
chromatographytandem
mass
spectrometri
lcmsm
proteom
bronchoalveolar
lavag
bal
sampl
ard
subject
analyz
almost
result
uniqu
protein
focus
secret
protein
author
identifi
increas
insulinlik
growth
factorbind
ligand
insulin
growth
factor
earli
ard
suggest
contribut
fibroblast
surviv
ard
sever
investig
sinc
report
identif
increas
bal
apolipoprotein
calciumbind
protein
inflammatori
protein
includ
acut
phase
protein
cytokin
investig
plasma
compart
chen
colleagu
identifi
protein
differenti
express
ard
patient
compar
healthi
control
ard
subject
show
significantli
downregul
plasma
apolipoprotein
apo
ai
aiv
cii
ciii
complement
factor
h
upregul
complement
serum
amyloid
creactiv
protein
conson
individu
protein
find
dysregul
pathway
annot
acut
phase
signal
complement
system
signal
product
nitric
oxid
reactiv
oxygen
speci
complementari
approach
proteom
examin
small
molecul
metabolit
profil
either
blood
lung
compart
order
gain
inform
physiolog
process
occur
compart
metabolit
intermedi
product
metabol
endogen
exogen
peptid
also
lipid
carbohydr
amino
acid
nucleotid
hormon
vitamin
foreign
chemic
substrat
drug
diet
exposur
metabolit
first
separ
ga
andor
liquid
chromatographi
quantifi
mass
spectrometri
isotopelabel
nuclear
magnet
reson
spectroscopi
hnmr
cnmr
stringer
colleagu
univers
michigan
first
report
hnmridentifi
metabolit
plasma
sepsisassoci
ard
subject
compar
healthi
control
forti
metabolit
identifi
ard
plasma
character
higher
adenosin
glutathion
sphingomyelin
phoshatidylserin
pathway
annot
analysi
suggest
metabolit
particip
uniqu
metabol
network
sepsisassoci
ard
sampl
compar
healthi
control
subject
plasma
remain
unclear
whether
analyt
identifi
specif
ard
whether
might
reflect
alter
sepsi
studi
ardsspecif
metabolit
would
requir
studi
nonard
septic
subject
control
metabolom
profil
plasma
appli
commonli
sepsi
seymour
identifi
numer
differ
initi
emerg
depart
plasma
sampl
sepsi
survivor
versu
nonsurvivor
match
subject
clinic
characterist
procalcitonin
level
metabol
bile
acid
sterol
amino
acid
nucleotid
energi
among
dysregul
pathway
nonsurvivor
langley
colleagu
perform
multipl
analys
compar
sepsi
survivor
noninfect
subject
present
noninfecti
system
inflammatori
respons
syndrom
sir
also
sepsi
survivor
nonsurvivor
progress
declin
glycerophosphocholin
glycerophosphoethanolamin
ester
among
septic
subject
pronounc
among
nonsurvivor
well
increas
lactat
increas
carnitin
ester
product
fatti
acid
metabol
nonsurvivor
one
limit
metabolom
investig
lack
consensu
analyt
strategi
use
multipl
layer
larg
data
fact
highlight
second
metabolom
investig
popul
langley
studi
done
revers
order
differ
analyt
strategi
roger
colleagu
first
identifi
valid
individu
metabolit
associ
death
critic
ill
develop
iter
bayesian
network
risk
stratifi
mortal
compar
langley
studi
identifi
critic
metabolit
clinic
variabl
age
hematocrit
lactat
predict
model
roger
model
identifi
clinic
data
metabolit
distinct
chosen
langley
model
pediatr
septic
popul
mickiewicz
appli
hnmr
spectroscopi
serum
sampl
demonstr
princip
compon
analysi
metabol
profil
septic
shock
differ
healthi
children
sir
septic
shock
character
increas
level
metabolit
associ
muscl
turnov
amino
acid
oxid
decreas
energi
suppli
field
metabolom
seem
ripe
develop
consensu
recommend
govern
analyt
approach
need
independ
replic
prompt
metaanalysi
applic
unsupervis
learn
methodolog
class
predict
bronchoalveolar
lavag
fluid
pose
challeng
metabolom
due
fluid
high
protein
salt
content
rel
low
concentr
metabolit
howev
evan
colleagu
recent
overcam
limit
test
bal
fluid
multipl
highperform
liquid
chromatographi
platform
determin
optim
perform
revers
phase
hydrophil
interact
chromatographi
prior
mass
spectrometri
conson
proteom
studi
ard
bal
fluid
demonstr
reduc
surfact
protein
evan
report
measur
reduc
phosphatidylcholin
major
phospholipid
pulmonari
surfact
bal
fluid
among
ard
subject
alveolar
fluid
ard
subject
also
demonstr
higher
level
product
associ
energi
metabol
lactat
citrat
creatin
creatinin
similarli
increas
plasma
ard
patient
novel
find
sever
guanosin
network
metabolit
increas
ard
bal
fluid
prompt
reexamin
xanthin
oxidas
activ
lung
injuri
model
common
thread
review
variou
omic
approach
exponenti
growth
complex
data
fuel
major
technolog
advanc
explos
data
creat
new
challeng
comput
power
analysi
similarli
new
opportun
describ
multipl
aspect
human
data
fit
togeth
groundbreak
exampl
integr
think
pair
whole
genom
genotyp
tissuespecif
gene
express
identifi
genet
determin
specif
trait
use
annot
enrich
analysi
determin
transcript
factor
critic
obes
coronari
arteri
diseas
cad
approach
sometim
term
network
biolog
particularli
success
help
priorit
mechanist
studi
translat
observ
human
popul
back
laboratori
test
causal
one
notabl
exampl
rader
colleagu
built
demonstr
one
genet
variant
strongli
associ
cad
low
densiti
lipoprotein
ldl
cholesterol
level
hepat
express
sortilin
gene
investig
perform
fine
map
snp
linkag
disequilibrium
block
identifi
function
variant
replic
genet
associ
popul
differ
ancestr
background
use
overexpress
knockdown
experi
mice
prove
express
modifi
plasma
ldl
novel
pathway
ldl
regul
identifi
thu
network
analysi
integr
multipl
thread
data
suggest
put
candid
mechanist
follow
help
priorit
function
candid
suggest
causal
pathway
act
network
scienc
effect
multipl
platform
systemat
data
acquisit
thu
leverag
success
sever
cancer
network
common
trait
like
cad
investig
begin
gather
ardsspecif
systemat
data
network
base
approach
may
prove
feasibl
futur
complex
may
ad
system
consid
human
interactom
also
interact
human
host
resid
microbi
flora
yet
wide
appli
lung
injuri
model
care
examin
gut
microbiota
anim
model
metabol
syndrom
demonstr
critic
interact
inflammasom
signal
gut
microflora
microb
shape
genet
architectur
global
popul
natur
select
may
dynam
partner
evolut
complex
phenotyp
like
ard
next
gener
sequenc
technolog
make
possibl
character
lung
microbiom
may
yield
import
insight
futur
acut
respiratori
distress
syndrom
complex
trait
pois
benefit
applic
high
throughput
technolog
assay
dna
mrna
protein
metabolit
microbiom
system
though
hinder
infrequ
access
lung
tissu
research
made
import
advanc
earli
applic
multipl
omic
applic
appli
lesson
nonard
phenotyp
highlight
potenti
techniqu
expand
pathophysiolog
understand
new
discoveri
ard
await
applic
test
analyt
name
like
potenti
applic
highlight
x
